The December 2025 TRIUMPH-4 results showed retatrutide reducing systolic blood pressure by 14 mmHg at the 12mg dose
Clinical trial results are described as spanning roughly 5% to 22% of baseline body weight, and real-world data from compounded and branded users shows similar heterogeneity, with some people losing 5-10% and others achieving over 20%
Because GLP-1 medications often lead to smaller meals and lower overall intake, maintaining adequate vitamin D through food alone may become more difficult over time
Enterobacteriaceae , and Enterococci bacteria, which can deconjugate BAs from taurine or glycine to produce deoxycholic acid (DCA) and lithocholic acid (LCA)
If further studies confirm these findings, semaglutide could shift the focus of Alzheimers prevention strategies , encouraging earlier intervention in patients at risk due to diabetes, obesity, or cardiovascular disease